Markets › United States › NAS › ANIK

Anika Therapeutics Inc

NAS:ANIKHealthcareCBOEFTSE:MRUTNASDAQ:NCX

$21.14+0.24%LiveIn session · ≈ AED 77.64 · Market cap $282.92M · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	52.9%	56.1%	64.3%	68.3%	63.4%	56.6%	—	—
Operating margin	−21.7%	1.8%	3.2%	0.7%	−4.3%	−9.8%	−9.8%	+0.0 pts
Net margin	−18.4%	2.8%	−13.1%	−68.4%	−47.0%	−9.6%	−9.6%	+0.0 pts
EBITDA margin	−0.8%	−2.8%	16.5%	14.4%	4.5%	−3.2%	—	—
Return on equity	−8.8%	1.4%	−5.2%	−38.9%	−36.6%	−7.6%	−7.6%	+0.0 pts
Return on assets	−6.6%	1.2%	−4.3%	−30.5%	−27.8%	−5.7%	−5.7%	+0.0 pts
Return on capital employed	−8.6%	0.8%	1.1%	0.4%	−2.8%	−6.6%	—	—
Debt / equity	0.1×	0.1×	0.1×	0.1×	0.2×	0.2×	0.2×	+0.0%
Debt / assets	6.1%	6.0%	8.8%	10.3%	12.8%	13.8%	—	—
Interest coverage	−35.4×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	4.8×	5.7×	6.1×	5.3×	4.9×	4.7×	4.7×	+0.0%
Quick ratio	3.6×	4.4×	4.6×	4.5×	3.9×	3.9×	—	—
Cash ratio	2.6×	3.2×	3.1×	2.2×	2.4×	2.6×	2.6×	+0.0%
Asset turnover	0.4×	0.4×	0.3×	0.4×	0.6×	0.6×	—	—
Inventory turnover	1.3×	1.8×	1.0×	1.6×	1.8×	2.6×	—	—
Receivables turnover	5.4×	5.0×	3.3×	4.6×	5.1×	4.8×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—